Elanco Animal Health Inc. (ELAN) Q4 2024 Annual Earnings
ELAN·Reported February 25, 2025·Before market open
Elanco Animal Health Inc. reported Q4 2024 revenue of $1.0B, missed analyst consensus of $1.2B by $189.9M. Diluted EPS came in at $0.14, missed the $0.16 consensus by $0.02.
Revenue
$1.0Bmissed by $189.9M
Consensus: $1.2BDiluted EPS
$0.14missed by $0.02
Consensus: $0.16
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Elanco Animal Health Inc.'s Q4 2024 earnings report.
Elanco Animal Health Inc. (ELAN) reported Q4 2024 earnings on February 25, 2025 before market open.
Elanco Animal Health Inc. reported revenue of $1.0B and diluted EPS of $0.14 for Q4 2024.
Revenue missed the consensus estimate of $1.2B by $189.9M. EPS missed the consensus estimate of $0.16 by $0.02.
You can read the 10-K periodic report (0001739104-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.